News
-
-
PRESS RELEASE
MindBio Therapeutics Scientists Present Landmark Women’s Health Trials. Company To Release Phase 2A Depression Trial Secondary Data This Month
MindBio Therapeutics Corp. presents groundbreaking women's health trials for microdosing treatments, showcasing Dr. Rachael Sumner and upcoming data release on Phase 2A trial results. Chief Executive Justin Hanka discusses future growth plans -
PRESS RELEASE
EQS-Adhoc: European Healthcare Acquisition & Growth Company B.V. announces change in CEO position
European Healthcare Acquisition & Growth Company B.V. announces change in CEO position. Dr. Thomas Rudolph appointed as new CEO and compliance officer following Dr. Cornelius H. Baur's resignation -
PRESS RELEASE
ENCAVIS AG Management Board and Supervisory Board recommend the acceptance of the voluntary public takeover offer by KKR
Encavis AG Management Board and Supervisory Board recommend accepting KKR's public takeover offer at EUR 17.50 per share as fair and attractive, aligning with growth strategy -
PRESS RELEASE
Nano One et Worley signent des Accords de licence et d'alliance pour développer, commercialiser et déployer conjointement une conception d’usine de cathode
Nano One® et Worley Chemetics® concluent un accord stratégique et de licence pour le déploiement de nouvelles technologies de production de matériaux de cathode, visant à réduire les coûts et accélérer les projets dans le secteur des batteries lithium-ion -
PRESS RELEASE
Edison issues flash on Picton Property Income (PCTN): Unlocking value to drive DPS growth
Edison issues a flash report on Picton Property Income (PCTN), highlighting DPS growth and value unlocking strategies. The company aims for fully covered dividends at an annualised run rate of 3.7p -
PRESS RELEASE
Original-Research: Marley Spoon Group SE (von NuWays AG): Kaufen
Marley Spoon Group SE released healthy Q1'24 results in line with expectations, with a focus on subscriber growth, improved margins, and confirmed FY'24 guidance. NuWays AG provided an update and recommended buying with a target price of EUR 7.00 -
-
-
